Objective: Determine the prevalence of benzodiazepine use, including both use as-prescribed and misuse; characterize misuse; determine whether and how misuse varies by age. Methods: Cross-sectional analysis of the 2015 and 2016 National Survey on Drug Use and Health (NSDUH), a nationally-representative sample of U.S. adults (n=86,186). Measurements included past-year prescription benzodiazepine use and misuse (i.e., use "any way a doctor did not direct"), along with substance use and use disorders, mental illness, and demographic characteristics. Misuse was compared between younger (18-49) and older (≥50) adults. Results: 30.6 million adults (12.6%) reported past-year benzodiazepine use annually: 25.3 million (10.4%) as-prescribed and 5.3 million (2.2%) with misuse. Misuse accounted for 17.2% of benzodiazepine use overall. Adults 50-64 had the highest prescribed use (12.9%). Those 18-25 had the highest misuse (5.2%), while adults ≥65 had the lowest (0.6%). Misuse and abuse or dependence of prescription stimulants or opioids were strongly associated with benzodiazepine misuse. Misuse without a prescription was the most common type of misuse, while a friend or relative was the most common source. Adults ≥50 were more likely to use a benzodiazepine more often than prescribed and to help with sleep. Conclusions: Benzodiazepine use in the U.S. is higher than previously reported and misuse accounted for nearly 20% of use overall. Use among adults 50-64 has now exceeded use by those ≥65. Clinicians should monitor patients also prescribed stimulants or opioids for benzodiazepine misuse. Improved access to behavioral interventions for sleep or anxiety may reduce some misuse.